Edwards Lifesciences Corporation Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 02/11/2025 | 69.13 M | $5.12 B | 10.44% | 11.58% |
BLACKROCK, INC. | 02/07/2025 | 54.52 M | $4.04 B | -0.12% | 9.13% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 33.21 M | $2.46 B | 5.32% | 5.56% |
STATE STREET CORP | 02/14/2025 | 25.81 M | $1.91 B | -1.74% | 4.32% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 18.13 M | $1.34 B | -0.99% | 3.04% |
JPMORGAN CHASE & CO | 02/12/2025 | 14.85 M | $1.10 B | 75.43% | 2.49% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 13.65 M | $1.01 B | 0.93% | 2.29% |
FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 9.78 M | $723.66 M | 7.68% | 1.64% |
CITADEL ADVISORS LLC | 02/14/2025 | 9.42 M | $697.22 M | 372.91% | 1.58% |
NORGES BANK | 02/12/2025 | 8.25 M | $610.90 M | 100.00% | 1.38% |
BROWN ADVISORY INC | 02/14/2025 | 8.16 M | $603.74 M | 7.60% | 1.37% |
JENNISON ASSOCIATES LLC | 01/24/2025 | 7.51 M | $555.94 M | 100.00% | 1.26% |
NINETY ONE UK LTD | 01/27/2025 | 7.18 M | $531.88 M | -1.74% | 1.20% |
MORGAN STANLEY | 02/14/2025 | 7.14 M | $528.33 M | 24.75% | 1.20% |
DEUTSCHE BANK AG\ | 02/14/2025 | 6.90 M | $511.04 M | 10.45% | 1.16% |
UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 6.52 M | $482.62 M | 8.55% | 1.09% |
NORTHERN TRUST CORP | 02/14/2025 | 6.51 M | $481.58 M | 21.83% | 1.09% |
MARSHALL WACE, LLP | 02/13/2025 | 5.81 M | $430.37 M | 55.70% | 0.97% |
WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST | 01/13/2025 | 4.80 M | $355.34 M | 6.67% | 0.80% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 4.62 M | $341.66 M | 24.95% | 0.77% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 4.24 M | $314.18 M | 475.77% | 0.71% |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 4.22 M | $312.43 M | -2.89% | 0.71% |
INVESCO LTD. | 02/13/2025 | 4.18 M | $309.48 M | 30.71% | 0.70% |
NORDEA INVESTMENT MANAGEMENT AB | 01/06/2025 | 4.06 M | $301.35 M | 34.63% | 0.68% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 3.76 M | $278.56 M | 2.83% | 0.63% |
AMUNDI | 02/07/2025 | 3.32 M | $246.27 M | -4.63% | 0.56% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 3.30 M | $244.13 M | -6.89% | 0.55% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 3.17 M | $234.67 M | -6.40% | 0.53% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 3.00 M | $221.74 M | 27.91% | 0.50% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 2.89 M | $213.84 M | 100.00% | 0.48% |
CHAMPLAIN INVESTMENT PARTNERS, LLC | 02/13/2025 | 2.82 M | $208.89 M | -8.41% | 0.47% |
OWNERSHIP CAPITAL B.V. | 02/03/2025 | 2.79 M | $206.71 M | -6.71% | 0.47% |
UBS GROUP AG | 02/14/2025 | 2.69 M | $198.85 M | 50.05% | 0.45% |
AUSTRALIANSUPER PTY LTD | 01/30/2025 | 2.67 M | $197.57 M | -18.47% | 0.45% |
FMR LLC | 02/13/2025 | 2.43 M | $179.80 M | 31.34% | 0.41% |
HOLOCENE ADVISORS, LP | 02/14/2025 | 2.41 M | $178.42 M | -14.15% | 0.40% |
ROYAL BANK OF CANADA | 02/14/2025 | 2.29 M | $169.36 M | 16.03% | 0.38% |
STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD | 01/22/2025 | 2.20 M | $163.03 M | -3.41% | 0.37% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.19 M | $162.34 M | -31.77% | 0.37% |
PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 2.04 M | $151.28 M | 14.50% | 0.34% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 2.04 M | $150.92 M | -70.81% | 0.34% |
HSBC HOLDINGS PLC | 02/14/2025 | 1.97 M | $146.20 M | -7.88% | 0.33% |
MIROVA US LLC | 02/10/2025 | 1.81 M | $133.94 M | -2.89% | 0.30% |
DEKABANK DEUTSCHE GIROZENTRALE | 01/29/2025 | 1.75 M | $130.62 M | 0.00% | 0.29% |
SWISS NATIONAL BANK | 02/10/2025 | 1.70 M | $125.98 M | -4.85% | 0.29% |
LIONTRUST INVESTMENT PARTNERS LLP | 02/13/2025 | 1.61 M | $119.22 M | 33.29% | 0.27% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 1.57 M | $116.45 M | 206.17% | 0.26% |
RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 1.52 M | $112.69 M | 20.06% | 0.25% |
01/16/2025 | 1.48 M | $109.49 M | 100.00% | 0.25% | |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 1.42 M | $105.19 M | -4.14% | 0.24% |
Edwards Lifesciences Corporation institutional Ownership - FAQ's
During the previous two years, 1706 institutional investors and hedge funds held shares of Edwards Lifesciences Corporation. The most heavily invested institutionals were:
VANGUARD GROUP INC: 69.13 M
BlackRock, Inc.: 54.52 M
WELLINGTON MANAGEMENT GROUP LLP: 33.21 M
STATE STREET CORP: 25.81 M
Bank of New York Mellon Corp: 18.13 M
JPMORGAN CHASE & CO: 14.85 M
83.93% of Edwards Lifesciences Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 598.86 M shares in the last 24 months. This purchase volume represents approximately $41.56 B in transactions.